Intuitive Surgical (ISRG) Expected to Announce Earnings on Tuesday

Key Points

• Intuitive Surgical is expected to report Q3 2026 results after market close on October 20. Analysts forecast earnings of $2.65 per share on $2.91 billion in revenue.
• The company’s latest quarter exceeded expectations, with EPS of $2.80 versus the $2.48 consensus and revenue of $2.89 billion, up 18.4% year over year.
• Analysts maintain a consensus “Moderate Buy” rating with an average price target of $501.98, while shares recently opened at $427.64; insiders sold $4.9 million of stock during the last quarter.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) is projected to release its Q3 2026 results after the market closes on Tuesday, October 20th. Analysts expect Intuitive Surgical to announce earnings of $2.65 per share and revenue of $2.91 billion for the quarter. Parties may visit the company's upcoming Q3 2026 earnings report page for the latest details on the call scheduled for Tuesday, October 20, 2026 at 4:30 PM ET.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, beating the consensus estimate of $2.48 by $0.32. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%. The company had revenue of $2.89 billion during the quarter, compared to the consensus estimate of $2.83 billion. During the same period last year, the business posted $1.81 EPS. The firm's revenue for the quarter was up 18.4% compared to the same quarter last year. On average, analysts expect Intuitive Surgical to post $8.87 EPS for the current fiscal year and $10.02 EPS for the next fiscal year.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $427.64 on Tuesday. Intuitive Surgical has a one year low of $328.57 and a one year high of $603.88. The firm has a market capitalization of $151.08 billion, a price-to-earnings ratio of 48.99, a PEG ratio of 3.20 and a beta of 1.46. The business has a 50-day simple moving average of $387.41 and a 200 day simple moving average of $410.47.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, EVP Mark Brosius sold 77 shares of Intuitive Surgical stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $375.57, for a total transaction of $28,918.89. Following the completion of the transaction, the executive vice president owned 881 shares in the company, valued at approximately $330,877.17. The trade was a 8.04% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the business's stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $379.00, for a total value of $151,600.00. Following the sale, the executive vice president directly owned 5,320 shares of the company's stock, valued at $2,016,280. This represents a 6.99% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 12,370 shares of company stock valued at $4,891,989 over the last quarter. 0.60% of the stock is currently owned by company insiders.

Analyst Ratings Changes

ISRG has been the topic of several recent research reports. Sanford C. Bernstein reiterated an "outperform" rating on shares of Intuitive Surgical in a report on Wednesday, August 12th. Weiss Ratings restated a "hold (c)" rating on shares of Intuitive Surgical in a report on Friday, August 14th. HSBC lowered Intuitive Surgical from a "buy" rating to a "hold" rating and set a $391.00 target price on the stock. in a research report on Thursday, July 30th. Leerink Partners lowered their target price on Intuitive Surgical from $573.00 to $454.00 and set an "outperform" rating on the stock in a research report on Friday, July 17th. Finally, BNP Paribas Exane upgraded Intuitive Surgical to an "outperform" rating in a report on Tuesday, July 28th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-one have issued a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $501.98.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops and commercializes robotic-assisted systems and related technologies designed to support minimally invasive medical procedures. The company's products are intended to help surgeons perform operations through small incisions while providing enhanced visualization, precision, and control.

Its principal product is the da Vinci Surgical System, a platform used across a range of specialties, including general surgery, urology, gynecology, thoracic surgery, and cardiac procedures.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.